To evaluate the effect of TACC3 on bladder cancer (BC) growth in vivo, we established a xenograft model by subcutaneously injecting TACC3-knockdown 5637 cells and control cells into mice. The gene discussed is TACC3; the disease is urinary bladder carcinoma.